日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

您現在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 国产全肉乱妇杂乱视频 | 久久久久国产精品 | 久久久久久国产精品 | 日韩有码一区 | 成人毛片18岁女人毛片免费看 | 免费看黄网站在线 | 亚洲已满18点击进入在线观看 | 欧美性猛交一区二区三区精品 | 日本无码欧美激情在线视频 | 12av毛片 | 不卡一区在线观看 | 午夜在线免费观看视频 | 日韩在线观看视频网站 | 奇米色第四色 | 亚洲av一级毛片特黄大片 | 久久精品视频免费 | 日韩免费精品一级毛片 | 日韩欧美在线观看一区 | 黄色免费av| 色综色天天综合网 | 精品国产一区二区国模嫣然 | 日韩一区二区视频 | 欧美成人观看 | 成人在线精品 | 香港论理午夜电影网 | 91天堂| 夫妻性生活交换 | 欧美日韩精品一区二区在线线 | 久久久亚洲欧洲日产国码606 | 爱爱视频网站 | 久久综合日韩亚洲精品色 | 日日摸夜夜添夜夜添亚洲女人 | 国产麻豆传媒视频 | av一级毛片 | 午夜影院在线观看版 | 免费啪视频在线观看免费的 | 亚洲国产国产综合一区首页 | 日本一区二区高清不卡 | 成人激情四射 | 成人国产网站 | 国产福利视频在线观看 |